Background and aims Non-alcoholic steatohepatitis (NASH), the potentially progressive form of nonalcoholic fatty liver disease (NAFLD), is the pandemic liver disease of our time. Although there are several animal models of NASH, consensus regarding the optimal model is lacking. We aimed to compare features of NASH in the two most widely-used mouse models: methionine-choline deficient (MCD) diet and Western diet. Methods Mice were fed standard chow, MCD diet for 8 weeks, or Western diet (45 % energy from fat, predominantly saturated fat, with 0.2 % cholesterol, plus drinking water supplemented with fructose and glucose) for 16 weeks. Liver pathology and metabolic profile were compared. Results The metabolic profile associated with human NASH...
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western wo...
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western wo...
Background & AimsThe lack of a preclinical model of progressive non-alcoholic steatohepatitis (NASH)...
International audienceBACKGROUND AND AIMS: Non-alcoholic steatohepatitis (NASH), the potentially pro...
<div><p>Background and aims</p><p>Non-alcoholic steatohepatitis (NASH), the potentially progressive ...
Non-alcoholic steatohepatitis (NASH), the potentially progressive form of nonalcoholic fatty liver d...
BACKGROUND AND AIMS: Non-alcoholic steatohepatitis (NASH), the potentially progressive form of nonal...
Background Nonalcoholic fatty liver disease (NAFLD) is a major public health burden in western socie...
A variety of dietary nonalcoholic steatohepatitis (NASH) mouse models are available, and choosing th...
A variety of dietary nonalcoholic steatohepatitis (NASH) mouse models are available, and choosing th...
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western wo...
A variety of dietary nonalcoholic steatohepatitis (NASH) mouse models are available, and choosing th...
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western wo...
A variety of dietary nonalcoholic steatohepatitis (NASH) mouse models are available, and choosing th...
A variety of dietary nonalcoholic steatohepatitis (NASH) mouse models are available, and choosing th...
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western wo...
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western wo...
Background & AimsThe lack of a preclinical model of progressive non-alcoholic steatohepatitis (NASH)...
International audienceBACKGROUND AND AIMS: Non-alcoholic steatohepatitis (NASH), the potentially pro...
<div><p>Background and aims</p><p>Non-alcoholic steatohepatitis (NASH), the potentially progressive ...
Non-alcoholic steatohepatitis (NASH), the potentially progressive form of nonalcoholic fatty liver d...
BACKGROUND AND AIMS: Non-alcoholic steatohepatitis (NASH), the potentially progressive form of nonal...
Background Nonalcoholic fatty liver disease (NAFLD) is a major public health burden in western socie...
A variety of dietary nonalcoholic steatohepatitis (NASH) mouse models are available, and choosing th...
A variety of dietary nonalcoholic steatohepatitis (NASH) mouse models are available, and choosing th...
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western wo...
A variety of dietary nonalcoholic steatohepatitis (NASH) mouse models are available, and choosing th...
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western wo...
A variety of dietary nonalcoholic steatohepatitis (NASH) mouse models are available, and choosing th...
A variety of dietary nonalcoholic steatohepatitis (NASH) mouse models are available, and choosing th...
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western wo...
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western wo...
Background & AimsThe lack of a preclinical model of progressive non-alcoholic steatohepatitis (NASH)...